- Nachrichtendetail
-
04.04.2024 12:53:46 - dpa-AFX: *MERCK INITIATES PHASE 3 TRIAL OF MK-1084 WITH FOR FIRST-LINE TREATMENT OF CERTAIN PATIENTS WITH METASTATIC NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,480 | 14.06.24 22:00:05 | +0,110 | +0,09% | 129,000 | 129,600 | 129,160 | 129,370 |
